Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Locate Bio

Locate Bio
2001 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series A LATEST DEAL TYPE
$2.61M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of a medicine development platform intended to offer regenerative medicines. The company's platform develops thermally-activated and injectable scaffolds that solidifies within the body and can be used to support tissue growth before degrading away, enabling pharmaceutical delivery, medical device and biotechnology companies to provide advanced delivery systems and regenerative matrices.

Formerly Known As
Regentec, Locate Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • MediCity
  • Thane Road, Beeston
  • Nottingham NG90 6BH
  • England, United Kingdom

+44 0115 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Locate Bio’s full profile, request a free trial.

Locate Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 28-Sep-2018 $2.61M 00.000 000.00 Completed Generating Revenue
3. Grant 11-Feb-2016 00.000 Completed Generating Revenue
2. Corporate 09-May-2014 $3.51M $3.51M 00.00 Completed Generating Revenue
1. Grant 01-Jan-2013 $4.04M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Locate Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.000000 00.0 00.0 00 00.0 00.000
Ordinary 1,071,458 $0.000130 $1.09 $1.09 1x $1.09 12.62%
Ordinary 368,027 $0.000130 $0.68 $0.68 1x $0.68 4.33%
To view this company’s complete Cap Table, request access »

Locate Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
Heraeus Holding Holding Company Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Wellcome Trust Limited Partner 000 0000 000000 0

Locate Bio Executive Team (4)

Name Title Board
Seat
Contact
Info
Nick Staples Ph.D Chief Executive Officer
Kevin Shakesheff Chief Scientific Officer
Robin Andrew Quirk Ph.D Executive Director & Founder
John Von Benecke Chief Financial Officer & Chief Operating Officer

Locate Bio Board Members (6)

Name Representing Role Since Contact
Info
Andrew Roger Williamson Locate Bio Board Member 000 0000
Catherine Beech MD Self Board Member 000 0000
Ian Wilding Ph.D Self Chairman 000 0000
Peter Dines Mercia Asset Management Board Member 000 0000
Thomas Kluge Ph.D Locate Bio Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »